- Home
- VPG vs CMPX Comparison
VPG vs CMPX Comparison
Compare VPG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPG
- CMPX
- Stock Information
- Founded
- VPG 2009
- CMPX 2014
- Country
- VPG United States
- CMPX United States
- Employees
- VPG N/A
- CMPX 35
- Industry
- VPG Electrical Products
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- VPG Technology
- CMPX Health Care
- Exchange
- VPG Nasdaq
- CMPX Nasdaq
- Market Cap
- VPG 268.9M
- CMPX 291.8M
- IPO Year
- VPG N/A
- CMPX N/A
- Fundamental
- Price
- VPG $25.33
- CMPX $2.13
- Analyst Decision
- VPG Hold
- CMPX Strong Buy
- Analyst Count
- VPG 1
- CMPX 8
- Target Price
- VPG $31.00
- CMPX $13.13
- AVG Volume (30 Days)
- VPG 186.5K
- CMPX 804.2K
- Earning Date
- VPG 05-06-2025
- CMPX 05-08-2025
- Dividend Yield
- VPG N/A
- CMPX N/A
- EPS Growth
- VPG N/A
- CMPX N/A
- EPS
- VPG 0.23
- CMPX N/A
- Revenue
- VPG $297,480,000.00
- CMPX $850,000.00
- Revenue This Year
- VPG N/A
- CMPX N/A
- Revenue Next Year
- VPG $6.35
- CMPX N/A
- P/E Ratio
- VPG $112.37
- CMPX N/A
- Revenue Growth
- VPG N/A
- CMPX N/A
- 52 Week Low
- VPG $18.57
- CMPX $0.77
- 52 Week High
- VPG $35.11
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- VPG 51.21
- CMPX 57.65
- Support Level
- VPG $25.45
- CMPX $2.06
- Resistance Level
- VPG $27.00
- CMPX $2.23
- Average True Range (ATR)
- VPG 0.96
- CMPX 0.12
- MACD
- VPG -0.18
- CMPX 0.01
- Stochastic Oscillator
- VPG 8.55
- CMPX 69.23
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.